DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies ...
Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...
Guillaume Baillaird, CEO of ControlRad Systems, described how his company's technology can significantly reduce ...
Robert Schwartz, M.D., medical director at the Minnesota Heart Institute, explains new applications for denervation ...
November 2, 2015 — Miracor Medical Systems GmbH announced that its PiCSO system was highlighted during the 2015 ...
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...
October 30, 2015 — Results from the SHIELD I (Coronary InterventionS in HIgh-Risk PatiEnts Using a Novel Percutaneous ...
Ziad Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York ...
Sunil Rao, M.D., associate professor of medicine and a member in the Duke University Clinical Research Institute, a ...
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford ...
Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of Adelaide ...
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
Manesh Patel, M.D., associate professor of medicine, and director of interventional cardiology and the cath labs at Duke ...
October 27, 2015 — A large observational registry found that initial aortic valve replacement (AVR) in asymptomatic ...
October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA sirolimu ...